IMPSOBON Canadian Trademark Information

On Tuesday, September 1, 2009, a canadian trademark registration was filed for IMPSOBON by Novartis AG *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1450189. The current status of this trademark filing is Interruption of proceeding. The IMPSOBON trademark is filed in the description of Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, namely, metabolic myophathies, mucolipidoses, gangliosidoses, acidosis and alkadosis; anti-inflammatories; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, in oncology, in hematology, namely, blood and blood forming organs, in ophthalmology, in gastroenterology and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system relating to transplantation; anti-infectives, anti-bacterials, antivirals, anti-biotics, fungal medications. , Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, namely, metabolic myophathies, mucolipidoses, gangliosidoses, acidosis and alkadosis; anti-inflammatories; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, in oncology, in hematology, namely, blood and blood forming organs, in ophthalmology, in gastroenterology and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system relating to transplantation; anti-infectives, anti-bacterials, antivirals, anti-biotics, fungal medications. , Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, namely, metabolic myophathies, mucolipidoses, gangliosidoses, acidosis and alkadosis; anti-inflammatories; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, in oncology, in hematology, namely, blood and blood forming organs, in ophthalmology, in gastroenterology and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system relating to transplantation; anti-infectives, anti-bacterials, antivirals, anti-biotics, fungal medications. .